Tax Management India. Com
Law and Practice  :  Digital eBook
Research is most exciting & rewarding
  TMI - Tax Management India. Com
Follow us:
  Facebook   Twitter   Linkedin   Telegram
Central Excise - Tariff - Notifications

Home Notifications 1994 Central Excise Central Excise - 1994 Central Excise - Tariff Miscellaneous Exemptions This

Effective rates of excise duty on specified goods falling under Chapter 30 - 75/94 - Central Excise - Tariff

  • Contents

Effective rates of excise duty on specified goods falling under Chapter 30

Notification No. 75/94-C.E.

Dated 29-3-1994

In exercise of the powers conferred by sub-section (1) of section 5A of the Central Excises and Salt Act, 1944 (1 of 1944), and in supersession of the notification of the Government of India in the Ministry of Finance (Department of Revenue) No. 8/94-Central Excises, dated the 1st March, 1994, the Central Government, being satisfied that it is necessary in the public interest so to do, hereby exempts the goods specified in column (3) of the Table hereto annexed and falling under Chapter or heading No. or sub-heading No. of the Schedule to the Central Excise Tariff Act, 1985 (5 of 1986), specified in column (2) of the said Table, from that portion of the duty of excise leviable thereon which is specified in the said Schedule as is in excess of the amount calculated at the rate specified in the corresponding entry in column (4) of the said Table, subject to the conditions, if any, specified in the corresponding entry in column (5) of the said Table.

TABLE

S. No.

Chapter or heading No. or sub-heading No.

Description of goods

Rate of Duty

Condition

(1)

(2)

(3)

(4)

(5)

1.

30

All formulations based on the list of bulk drugs specified in the First Schedule to the Drugs (Price Control) Order, 1987, as amended from time to time

Nil

-

2.

30

Insulin and Zidovudine

Nil

-

3.

3003.30

(i) Medicaments (inc-luding veterinary medi-caments) used in Ayur-vedic, Unani Tibb, Sidha or Homoeopathic Sys-tems, manufactured ex-clusively in accordance with the formulae des-cribed in the authori-tative books specified in the First Schedule to the Drugs and Cosmetics Act, 1940 (23 of 1940) or Homoeopathic Pharma-copoeia of India or the United States of America, or the United Kingdom or the German Homoeopathic Pharma-copoeia, as the case may be, and sold under the name as specified in such books or pharma-copoeia

Nil

-

 

 

(ii) Medicaments (inc-luding veterinary medi-caments) used in bio-chemic system and not bearing a brand name

Nil

-

 

 

(iii) Others

10% ad valorem

-

4.

30.04

Surgical absorbent lint

10% ad valorem

If such surgi-cal absorbent lint is packed in packets of one-half kilo-grams or less.

5.

30.04

Absorbent cotton wool, non-absorbent cotton wool and gauze cloth bandages

10% ad valorem

-

6.

30

Desferrioxamine messy-late injection, Desferrio-xamine injection, Desfe-rrioxamine methane sul-phonate injection

10% ad valorem

-

Explanation. - For the purpose of this notification, the expression, -

(i) bulk drugs" shall have the same meaning assigned to it in the Drugs (Prices Control) Order, 1987 and shall include their salts, esters or derivatives, if any.

(ii) "formulations" shall mean medicaments processed out of or containing one or more bulk drugs, with or without the use of any pharmaceutical aids (such as diluent, disintegrating agent, moistening agent, lubricant, buffering agent, stabiliser or preserver) which are therapeutically inert and do not interfere with therapeutical or prophylactic activity of the drugs, for internal or external use, or in the diagnosis, treatment, mitigation or prevention of disease in human beings or animals, but shall not include any substance to which the provisions of the Drugs and Cosmetics Act, 1940 (23 of 1940) do not apply.

(iii) "brand name" shall mean a name or a registered trade mark under the Trade and Merchandise Marks Act, 1958 (43 of 1958), or any other mark such as a symbol, monogram, label, signature or invented words or any writing which is used in relation to that medicine for the purpose of indicating or so as to indicate a connection in the course of trade between the medicine and some person, having the right either as proprietor or otherwise to use the name or trade mark or any other mark with or without any indication of the identity of that person.

 
 

 

Quick Updates:Latest Updates